Cargando…
The Evolution of Complex Muscle Cell In Vitro Models to Study Pathomechanisms and Drug Development of Neuromuscular Disease
Many neuromuscular disease entities possess a significant disease burden and therapeutic options remain limited. Innovative human preclinical models may help to uncover relevant disease mechanisms and enhance the translation of therapeutic findings to strengthen neuromuscular disease precision medic...
Autores principales: | Zschüntzsch, Jana, Meyer, Stefanie, Shahriyari, Mina, Kummer, Karsten, Schmidt, Matthias, Kummer, Susann, Tiburcy, Malte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997482/ https://www.ncbi.nlm.nih.gov/pubmed/35406795 http://dx.doi.org/10.3390/cells11071233 |
Ejemplares similares
-
SARS-CoV-2-Antikörper-Antwort auf die zweite COVID-19-Impfung bei neuromuskulären Patienten unter immunmodulierender Therapie
por: Hosseini, S. S. Justus, et al.
Publicado: (2022) -
Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy
por: Shahriyari, Mina, et al.
Publicado: (2022) -
Evidence of Two Novel LAMA2 Variants in a Patient With Muscular Dystrophy: Facing the Challenges of a Certain Diagnosis
por: Meyer, Stefanie, et al.
Publicado: (2022) -
Long‐term human IgG treatment improves heart and muscle function in a mouse model of Duchenne muscular dystrophy
por: Zschüntzsch, Jana, et al.
Publicado: (2020) -
Novel pathomechanisms in inflammatory neuropathies
por: Schafflick, David, et al.
Publicado: (2017)